[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

LAMEA Veterinary Oncology Market By Animal Type (Canine and Feline) By Therapy (Chemotherapy, Radiology, Surgery, Immunotherapy and Others) By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others) By Country, Industry Analysis and Forecast, 2020 - 2026

April 2020 | 90 pages | ID: L537089CC2B7EN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Latin America, Middle East and Africa Veterinary oncology Market would witness market growth of 14.2% CAGR during the forecast period (2020-2026).
Veterinary radiation oncology continues to advance with the introduction of emerging technology, procedures, and guidelines while growing patient outcome knowledge. They do face gaps in expertise and require randomized clinical trials to evaluate true results for clinicians, prognostic factors, dose tolerances, and toxicity.
In animals, lymphoma (lymphosarcoma) is a type of cancer characterized by the proliferation of malignant lymphocytes in solid organs such as the lymph nodes, bone marrow, liver, and spleen. The disorder can also occur in the gastrointestinal tract of the body, skin, and. Close supervision of dogs receiving chemotherapy is necessary because of the high risk of recurrence and resulting problems. The same refers to dogs who have reached remission and have ceased treatment. Disease and remission/recurrence control is normally done by peripheral lymph node palpation. This detects significant changes in peripheral lymph nodes. Some of the blood testing used to detect lymphoma often provide more objectivity and provide an early warning of an animal coming out of remission.
Wide resection is a type of curative-intent surgery: the aim is to resect the tumor burdens macroscopic (the primary tumor) and microscopic (satellite cells), including biopsy tracks. This surgical dosage is recommended for treating and handling solid tumors over intralesional and partial resections. Radical resection involves the replacement of a whole compartment of the tissue. Examples include removing a whole organ for the diagnosis of appendicular osteosarcomas, such as splenectomy to remove a splenic hemangiosarcoma or amputation of legs. Radical resection is sometimes required to completely remove the primary tumor and its accompanying pseudocapsule and satellite tumor cells, based on tumor location, type, and size.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.

Scope of the Study

Market Segmentation:

By Animal Type
  • Canine and
  • Feline
By Therapy
  • Chemotherapy
  • Radiology
  • Surgery
  • Immunotherapy and
  • Others
By Cancer Type
  • Lymphoma
  • Mast Cell Cancer
  • Mammary & Squamous Cell Cancer and
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Boehringer Ingelheim International GmbH
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
      • Elanco Animal Health, Inc.
  • Zoetis, Inc.
  • Varian Medical Systems, Inc.
  • PetCure Oncology, LLC (Accelitech, LLC)
  • AB Science SA
  • Rhizen Pharmaceuticals S.A.
      • Nippon Zenyaku Kogyo Co., Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 LAMEA Veterinary Oncology Market, by Animal Type
  1.4.2 LAMEA Veterinary Oncology Market, by Therapy
  1.4.3 LAMEA Veterinary Oncology Market, by Cancer Type
  1.4.4 LAMEA Veterinary Oncology Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. COMPETITION ANALYSIS - GLOBAL

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
  3.2.1 Partnerships, Collaborations and Agreements
  3.2.2 Product Launches and Product Expansions
  3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
  3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
  3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Sep – 2019, Nov) Leading Players

CHAPTER 4. LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE

4.1 LAMEA Canine Market by Country
4.2 LAMEA Feline Market by Country

CHAPTER 5. LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY

5.1 LAMEA Chemotherapy Market by Country
5.2 LAMEA Radiology Market by Country
5.3 LAMEA Surgery Market by Country
5.4 LAMEA Immunotherapy Market by Country
5.5 LAMEA Other Therapy Market by Country

CHAPTER 6. LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE

6.1 LAMEA Lymphoma Market by Country
6.2 LAMEA Mast Cell Cancer Market by Country
6.3 LAMEA Mammary & Squamous Cell Cancer Market by Country
6.4 LAMEA Others Market by Country

CHAPTER 7. LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY

7.1 Brazil Veterinary Oncology Market
  7.1.1 Brazil Veterinary Oncology Market by Animal Type
  7.1.2 Brazil Veterinary Oncology Market by Therapy
  7.1.3 Brazil Veterinary Oncology Market by Cancer Type
7.2 Argentina Veterinary Oncology Market
  7.2.1 Argentina Veterinary Oncology Market by Animal Type
  7.2.2 Argentina Veterinary Oncology Market by Therapy
  7.2.3 Argentina Veterinary Oncology Market by Cancer Type
7.3 UAE Veterinary Oncology Market
  7.3.1 UAE Veterinary Oncology Market by Animal Type
  7.3.2 UAE Veterinary Oncology Market by Therapy
  7.3.3 UAE Veterinary Oncology Market by Cancer Type
7.4 Saudi Arabia Veterinary Oncology Market
  7.4.1 Saudi Arabia Veterinary Oncology Market by Animal Type
  7.4.2 Saudi Arabia Veterinary Oncology Market by Therapy
  7.4.3 Saudi Arabia Veterinary Oncology Market by Cancer Type
7.5 South Africa Veterinary Oncology Market
  7.5.1 South Africa Veterinary Oncology Market by Animal Type
  7.5.2 South Africa Veterinary Oncology Market by Therapy
  7.5.3 South Africa Veterinary Oncology Market by Cancer Type
7.6 Nigeria Veterinary Oncology Market
  7.6.1 Nigeria Veterinary Oncology Market by Animal Type
  7.6.2 Nigeria Veterinary Oncology Market by Therapy
  7.6.3 Nigeria Veterinary Oncology Market by Cancer Type
7.7 Rest of LAMEA Veterinary Oncology Market
  7.7.1 Rest of LAMEA Veterinary Oncology Market by Animal Type
  7.7.2 Rest of LAMEA Veterinary Oncology Market by Therapy
  7.7.3 Rest of LAMEA Veterinary Oncology Market by Cancer Type

CHAPTER 8. COMPANY PROFILES

8.1 Boehringer Ingelheim International GmbH
  8.1.1 Company Overview
  8.1.2 Financial Analysis
  8.1.3 Segmental and Regional Analysis
  8.1.4 Research & Development Expense
  8.1.5 Recent strategies and developments:
    8.1.5.1 Partnerships, Collaborations, and Agreements:
    8.1.5.2 Acquisition and Mergers:
8.2 Karyopharm Therapeutics, Inc.
  8.2.1 Company overview
  8.2.2 Financial Analysis
  8.2.3 Research & Development Expenses
  8.2.4 Recent strategies and developments:
    8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Regeneus Ltd.
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Research & Development Expense
8.4 Elanco Animal Health, Inc.
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Regional Analysis
  8.4.4 Research & Development Expenses
  8.4.5 Recent strategies and developments:
    8.4.5.1 Acquisition and Mergers:
8.5 Zoetis, Inc.
  8.5.1 Company Overview
  8.5.2 Financial Analysis
  8.5.3 Regional Analysis
  8.5.4 Research & Development Expenses
  8.5.5 Recent strategies and developments:
    8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Varian Medical Systems, Inc.
  8.6.1 Company Overview
  8.6.2 Financial Analysis
  8.6.3 Segmental and Regional Analysis
  8.6.4 Research & Development Expense
  8.6.5 Recent strategies and developments:
    8.6.5.1 Acquisition and Mergers:
    8.6.5.2 Partnerships, Collaborations, and Agreements:
    8.6.5.3 Product Launches and Product Expansions:
8.7 PetCure Oncology, LLC (Accelitech, LLC)
  8.7.1 Company Overview
  8.7.2 Recent strategies and developments:
    8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 AB Science SA
  8.8.1 Company Overview
  8.8.2 Financial Analysis
  8.8.3 Research & Development Expense
8.9 Rhizen Pharmaceuticals S.A.
  8.9.1 Company Overview
8.1 Nippon Zenyaku Kogyo Co., Ltd.
  8.10.1 Company Overview

LIST OF TABLES

TABLE 1 LAMEA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– VETERINARY ONCOLOGY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– VETERINARY ONCOLOGY MARKET
TABLE 5 MERGERS & ACQUISITIONS – VETERINARY ONCOLOGY MARKET
TABLE 6 LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 7 LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 8 LAMEA CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 9 LAMEA CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 10 LAMEA FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 11 LAMEA FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 12 LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 13 LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 14 LAMEA CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 15 LAMEA CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 16 LAMEA RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 17 LAMEA RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 18 LAMEA SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 19 LAMEA SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 20 LAMEA IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 21 LAMEA IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 22 LAMEA OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 23 LAMEA OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 24 LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 25 LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 26 LAMEA LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 27 LAMEA LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 28 LAMEA MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 29 LAMEA MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 30 LAMEA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 31 LAMEA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 32 LAMEA OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 33 LAMEA OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 34 LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 35 LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 36 BRAZIL VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 37 BRAZIL VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 38 BRAZIL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 39 BRAZIL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 40 BRAZIL VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 41 BRAZIL VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 42 BRAZIL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 43 BRAZIL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 44 ARGENTINA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 45 ARGENTINA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 46 ARGENTINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 47 ARGENTINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 48 ARGENTINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 49 ARGENTINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 50 ARGENTINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 51 ARGENTINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 52 UAE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 53 UAE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 54 UAE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 55 UAE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 56 UAE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 57 UAE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 58 UAE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 59 UAE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 60 SAUDI ARABIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 61 SAUDI ARABIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 62 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 63 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 64 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 65 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 66 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 67 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 68 SOUTH AFRICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 69 SOUTH AFRICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 70 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 71 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 72 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 73 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 74 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 75 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 76 NIGERIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 77 NIGERIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 78 NIGERIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 79 NIGERIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 80 NIGERIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 81 NIGERIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 82 NIGERIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 83 NIGERIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 84 REST OF LAMEA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 85 REST OF LAMEA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 86 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 87 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 88 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 89 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 90 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 91 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 92 KEY INFORMATION – BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 93 KEY INFORMATION – KARYOPHARM THERAPEUTICS, INC.
TABLE 94 KEY INFORMATION – REGENEUS LTD.
TABLE 95 KEY INFORMATION – ELANCO ANIMAL HEALTH, INC.
TABLE 96 KEY INFORMATION – ZOETIS, INC.
TABLE 97 KEY INFORMATION –-VARIAN MEDICAL SYSTEMS, INC.
TABLE 98 KEY INFORMATION – PETCURE ONCOLOGY, LLC
TABLE 99 KEY INFORMATION – AB SCIENCE SA
TABLE 100 KEY INFORMATION – RHIZEN PHARMACEUTICALS S.A.
TABLE 101 KEY INFORMATION – NIPPON ZENYAKU KOGYO CO., LTD.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, SEP – 2019, NOV) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.


More Publications